Recent advances in the chromatographic determination of the most commonly used anti‐hepatitis C drug sofosbuvir and its co‐administered drugs in human plasma

MAH Abdel‐Tawab, MG Abd El‐Moghny… - Biomedical …, 2022 - Wiley Online Library
Sofosbuvir is a direct‐acting antiviral drug that inhibits hepatitis C virus (HCV) NS5B
polymerase, which in turn affects the virus replication inside biological systems. The clinical …

Analytical profiling of sofosbuvir as NS5B protein inhibitor for oral drug delivery: Method development and Validation

SW Rangari, SB Bari - Bulletin of Faculty of Pharmacy Cairo …, 2022 - bfopcu.eg.net
Hepatitis C virus (HCV) non-structural protein 5B (NS5B), which is being studied for its RNA-
dependent RNA polymerase (RDRP). It has been demonstrated that the RDRP is highly …

[HTML][HTML] Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form

A Rama, I Govindan, S Hebbar, A Chaturvedi… - …, 2023 - ncbi.nlm.nih.gov
Introduction: Posaconazole is a widely used antifungal drug, and its accurate quantification
is essential for quality control and assessment of its pharmaceutical products. This study …

Analytical and Bioanalytical Methods for the Quantification of the Nucleotide Polymerase Inhibitor-Sofosbuvir: A Critical Review (2015-2021)

S Pathak, M Bhardwaj, R Godela - Current Pharmaceutical …, 2023 - ingentaconnect.com
Sofosbuvir is a regularly used antiviral medication that was approved for clinical usage in
hepatitis C patients. Sofosbuvir belongs to the nucleotide analog drug class, and it operates …

Environmentally friendly analytical methods for quantitative measurement of sofosbuvir in pharmaceutical formulations: Comparison of HPTLC and UV …

KB Aher, GB Bhavar, MR Shelke… - Research Journal of …, 2023 - indianjournals.com
For the quantitative measurement of sofosbuvir (SFR) in pharmaceutical formulation, high-
performance thin-layer chromatographic (HPTLC) and environmentally friendly UV …

[PDF][PDF] Simultaneous Determination of Ledipasvir/Sofosbuvir by LC/MS/MS in Human Plasma and its Pharmacokinetics Application

M Raslan, EM Shehata, AR Sara… - Saudi J Med Pharm …, 2022 - saudijournals.com
Background: The rapid growth of COVID-19 infections may result in second wave of infection
and an overwhelmed health care providing systems. Ledipasvir and sofosbuvir can be a …